BioTrove to Discuss Company and Industry Developments at Leading Biotech Forum, August 9
Presentation webcast live at 3:10pm EDT
Woburn, MA, August 6, 2007 - BioTrove, Inc. today announced that its president and CEO, Albert Luderer, Ph.D., will participate in the Leerink Swann & Company Emerging Products and Applications of Life Science Tools Roundtable Conference, New York City, on August 9. Dr. Luderer is an invited speaker along with senior executives from companies including Affymetrix, Inc., Illumina, Inc., Applied Biosystems Group, Luminex Corporation and Helicos BioSciences Corporation.
"How our industry sector is valued is undergoing transformation. Our companies must demonstrate their abilities in accelerating research and product development - both in terms of productivity and product possibility," notes Albert Luderer, Ph.D., president and CEO, BioTrove, Inc.
"To advance genomics across multiple life science fields and demonstrate value, BioTrove has applied small volume technology to large clinical projects, from diagnostics to drug discovery. The business need of biopharma companies is clear - high-accuracy, high-throughput results driven by cost-sensitive technology. BioTrove has become part of the community due to its ability to meet that need," Dr. Luderer added.
Dr. Luderer is a panelist on emerging products and applications for high density microarrays, to take place at 1:30pm on August 9. Dr. Luderer's presentation on BioTrove will be broadcast live at 3:10pm via an audio webcast, accessible at www.wsw.com/webcast/leerink11/biotrove/.
About BioTrove, Inc.
BioTrove, Inc. offers two innovative technology platforms: RapidFire™, which enables the acceleration of drug discovery and pipeline decisions, and OpenArray™, which advances genomic research in a wide range of life science fields, including agriculture, disease research, bio-defense, and public health. With more than half of the world's ten largest pharmaceutical companies as clients, and partnerships with prestigious research and public health centers around the world, BioTrove's products and services ensure that an industry committed to accuracy and speed can meet business goals.
RapidFire™ Mass Spectrometry (RFMS) uses an innovative microfluidic technology to facilitate analysis at faster than 10 seconds per sample, eliminating the bottleneck created by traditional mass spectrometry throughput. RFMS is routinely used in many applications including the high-throughput screening of previously intractable drug targets, cytochrome P450 inhibition and other ADME assays and directed evolution studies.
The OpenArray™ Platform enables genomics researchers to generate SNP and real time qPCR data in the hundreds of thousands of data points per day, significantly increasing the number of samples analyzed while significantly decreasing the time and cost required. The flexible format and nanoliter scale of the OpenArray™ system allows for easy adjustment of sample and assay numbers, achieving economical, high-throughput genomics.
For more information, please visit www.biotrove.com or contact:
Dr. Albert Luderer, President and CEO
BioTrove, Inc.
781-721-3648
info@biotrove.com
Arielle Bernstein
Makovsky + Company
212-508-9643
abernstein@makovsky.com
|
